603983 丸美生物
2025/122024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)7.36810.1567.9395.554--
总资产报酬率 ROA (%)5.1107.1806.0704.435--
投入资产回报率 ROIC (%)5.9508.2916.9935.114--

边际利润分析
销售毛利率 (%)74.28673.70170.69468.39664.016
营业利润率 (%)8.57412.82714.34811.97316.731
息税前利润/营业总收入 (%)8.03012.34413.60111.19915.322
净利润/营业总收入 (%)7.13311.52812.4739.66913.497

收益指标分析
经营活动净收益/利润总额(%)82.64394.45761.64978.39485.313
价值变动净收益/利润总额(%)9.4635.00236.14915.8868.165
营业外收支净额/利润总额(%)-0.297-0.074-0.710-0.3663.434

偿债能力分析
流动比率 (X)1.8651.8512.5043.347--
速动比率 (X)1.6701.7132.3343.120--
资产负债率 (%)26.42931.92223.24320.555--
带息债务/全部投入资本 (%)14.67422.41412.6079.765--
股东权益/带息债务 (%)577.917344.168688.049916.806--
股东权益/负债合计 (%)273.207209.176323.331378.829--
利息保障倍数 (X)-15.485-26.085-21.034-15.332-7.644

营运能力分析
应收账款周转天数 (天)4.2534.4257.91113.2220.000
存货周转天数 (天)91.66990.20189.25995.4220.000